 Jason Burdick
Concepts (769)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 146 | 2026 | 701 | 28.150 |
Why?
| | Hyaluronic Acid | 82 | 2026 | 226 | 15.840 |
Why?
| | Tissue Engineering | 89 | 2026 | 439 | 15.010 |
Why?
| | Biocompatible Materials | 85 | 2026 | 429 | 13.780 |
Why?
| | Tissue Scaffolds | 41 | 2026 | 221 | 8.040 |
Why?
| | Bioprinting | 15 | 2026 | 33 | 7.710 |
Why?
| | Polymers | 43 | 2025 | 485 | 6.660 |
Why?
| | Printing, Three-Dimensional | 20 | 2026 | 101 | 5.400 |
Why?
| | Extracellular Matrix | 35 | 2026 | 562 | 5.320 |
Why?
| | Chondrogenesis | 24 | 2024 | 88 | 4.580 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 18 | 2017 | 80 | 4.560 |
Why?
| | Myocardial Infarction | 36 | 2025 | 1210 | 4.010 |
Why?
| | Cell Culture Techniques | 16 | 2025 | 372 | 3.660 |
Why?
| | Cartilage | 15 | 2024 | 197 | 2.970 |
Why?
| | Myocardium | 23 | 2026 | 934 | 2.790 |
Why?
| | Materials Testing | 24 | 2025 | 345 | 2.770 |
Why?
| | Ventricular Remodeling | 22 | 2026 | 278 | 2.730 |
Why?
| | Cross-Linking Reagents | 24 | 2026 | 206 | 2.650 |
Why?
| | Animals | 173 | 2026 | 38030 | 2.540 |
Why?
| | Delayed-Action Preparations | 14 | 2026 | 189 | 2.500 |
Why?
| | Spheroids, Cellular | 7 | 2025 | 74 | 2.440 |
Why?
| | Biomimetic Materials | 7 | 2024 | 78 | 2.380 |
Why?
| | Cell Movement | 16 | 2025 | 959 | 2.260 |
Why?
| | Nanotubes | 9 | 2016 | 46 | 2.260 |
Why?
| | Mechanotransduction, Cellular | 12 | 2025 | 121 | 2.230 |
Why?
| | Drug Carriers | 9 | 2018 | 136 | 2.190 |
Why?
| | Chondrocytes | 13 | 2026 | 232 | 2.190 |
Why?
| | Injections | 23 | 2026 | 199 | 2.100 |
Why?
| | Nanofibers | 8 | 2021 | 23 | 2.090 |
Why?
| | Light | 15 | 2026 | 403 | 1.990 |
Why?
| | Cell Adhesion | 23 | 2026 | 451 | 1.940 |
Why?
| | Stem Cells | 15 | 2020 | 628 | 1.930 |
Why?
| | Drug Delivery Systems | 17 | 2026 | 381 | 1.850 |
Why?
| | Lab-On-A-Chip Devices | 3 | 2026 | 61 | 1.840 |
Why?
| | Cartilage, Articular | 9 | 2021 | 349 | 1.740 |
Why?
| | Meniscus | 4 | 2025 | 23 | 1.710 |
Why?
| | beta-Cyclodextrins | 9 | 2025 | 32 | 1.700 |
Why?
| | Regeneration | 10 | 2019 | 197 | 1.500 |
Why?
| | Endothelial Cells | 8 | 2026 | 874 | 1.480 |
Why?
| | Cells, Cultured | 38 | 2025 | 4148 | 1.440 |
Why?
| | Swine | 23 | 2025 | 825 | 1.430 |
Why?
| | Ink | 5 | 2025 | 11 | 1.430 |
Why?
| | Osteogenesis | 7 | 2021 | 204 | 1.420 |
Why?
| | Adhesives | 3 | 2022 | 15 | 1.370 |
Why?
| | Cadherins | 4 | 2018 | 200 | 1.350 |
Why?
| | Hepatic Stellate Cells | 3 | 2016 | 14 | 1.340 |
Why?
| | Polyethylene Glycols | 21 | 2026 | 649 | 1.310 |
Why?
| | RNA, Small Interfering | 3 | 2018 | 637 | 1.290 |
Why?
| | Elastomers | 6 | 2026 | 30 | 1.290 |
Why?
| | Extracellular Vesicles | 5 | 2025 | 171 | 1.290 |
Why?
| | Rheology | 12 | 2025 | 94 | 1.260 |
Why?
| | Absorbable Implants | 8 | 2015 | 38 | 1.260 |
Why?
| | Microspheres | 12 | 2014 | 142 | 1.260 |
Why?
| | Stem Cell Transplantation | 5 | 2018 | 189 | 1.260 |
Why?
| | Cell Differentiation | 20 | 2023 | 2046 | 1.240 |
Why?
| | Mechanical Phenomena | 8 | 2018 | 80 | 1.230 |
Why?
| | Combinatorial Chemistry Techniques | 4 | 2018 | 17 | 1.230 |
Why?
| | Rats | 38 | 2026 | 5584 | 1.180 |
Why?
| | Cellular Microenvironment | 6 | 2022 | 93 | 1.160 |
Why?
| | Porosity | 10 | 2025 | 94 | 1.130 |
Why?
| | Glycerol | 4 | 2016 | 90 | 1.130 |
Why?
| | Antigens, CD | 3 | 2018 | 558 | 1.110 |
Why?
| | Fibroblasts | 9 | 2026 | 1025 | 1.100 |
Why?
| | Ventricular Function, Left | 14 | 2023 | 542 | 1.080 |
Why?
| | Biomedical Technology | 3 | 2020 | 50 | 1.070 |
Why?
| | Peptides | 7 | 2018 | 998 | 1.060 |
Why?
| | Cell Lineage | 4 | 2021 | 377 | 1.050 |
Why?
| | Biopolymers | 4 | 2024 | 35 | 1.040 |
Why?
| | Osteoblasts | 7 | 2008 | 145 | 1.040 |
Why?
| | Cell Survival | 19 | 2018 | 1100 | 0.990 |
Why?
| | Humans | 142 | 2026 | 145474 | 0.990 |
Why?
| | Myofibroblasts | 5 | 2021 | 148 | 0.970 |
Why?
| | Cryogels | 1 | 2026 | 3 | 0.950 |
Why?
| | Orthopedics | 3 | 2025 | 173 | 0.950 |
Why?
| | Infrared Rays | 4 | 2016 | 24 | 0.940 |
Why?
| | Transforming Growth Factor beta3 | 4 | 2021 | 15 | 0.930 |
Why?
| | Sepharose | 2 | 2025 | 32 | 0.930 |
Why?
| | Chemokine CXCL12 | 4 | 2021 | 86 | 0.930 |
Why?
| | Mice | 48 | 2026 | 18329 | 0.930 |
Why?
| | NIH 3T3 Cells | 10 | 2018 | 146 | 0.930 |
Why?
| | Bone Morphogenetic Protein 2 | 3 | 2015 | 76 | 0.920 |
Why?
| | Photochemical Processes | 7 | 2024 | 103 | 0.920 |
Why?
| | Dimethylpolysiloxanes | 2 | 2017 | 9 | 0.900 |
Why?
| | Regenerative Medicine | 6 | 2024 | 48 | 0.880 |
Why?
| | Synovial Membrane | 1 | 2026 | 123 | 0.870 |
Why?
| | Methacrylates | 8 | 2016 | 119 | 0.860 |
Why?
| | Adamantane | 6 | 2025 | 18 | 0.840 |
Why?
| | Cattle | 15 | 2025 | 946 | 0.820 |
Why?
| | Rats, Sprague-Dawley | 20 | 2026 | 2524 | 0.820 |
Why?
| | Collagen | 9 | 2025 | 457 | 0.820 |
Why?
| | Interleukin-10 | 5 | 2018 | 309 | 0.800 |
Why?
| | Guided Tissue Regeneration | 6 | 2015 | 13 | 0.800 |
Why?
| | Esters | 4 | 2022 | 71 | 0.770 |
Why?
| | Elastic Modulus | 12 | 2019 | 121 | 0.770 |
Why?
| | Signal Transduction | 10 | 2023 | 5216 | 0.750 |
Why?
| | Hyaluronan Receptors | 3 | 2019 | 104 | 0.740 |
Why?
| | Nanotechnology | 3 | 2014 | 114 | 0.720 |
Why?
| | Gels | 4 | 2025 | 85 | 0.720 |
Why?
| | Heart Ventricles | 8 | 2022 | 756 | 0.710 |
Why?
| | Endothelial Progenitor Cells | 5 | 2021 | 20 | 0.700 |
Why?
| | Oligopeptides | 5 | 2019 | 267 | 0.690 |
Why?
| | Tensile Strength | 13 | 2025 | 98 | 0.690 |
Why?
| | Stress, Mechanical | 12 | 2025 | 494 | 0.680 |
Why?
| | Cell Nucleus | 4 | 2025 | 588 | 0.680 |
Why?
| | Neovascularization, Physiologic | 10 | 2019 | 192 | 0.670 |
Why?
| | Decanoates | 3 | 2010 | 4 | 0.670 |
Why?
| | Photochemistry | 11 | 2009 | 127 | 0.670 |
Why?
| | Fractures, Cartilage | 3 | 2015 | 5 | 0.660 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 3 | 2018 | 9 | 0.660 |
Why?
| | Precision Medicine | 4 | 2025 | 459 | 0.640 |
Why?
| | Osteoarthritis | 4 | 2026 | 200 | 0.640 |
Why?
| | Suspensions | 3 | 2025 | 28 | 0.630 |
Why?
| | Nerve Growth Factors | 4 | 2009 | 78 | 0.620 |
Why?
| | Lactic Acid | 8 | 2010 | 295 | 0.620 |
Why?
| | Polyethyleneimine | 2 | 2016 | 19 | 0.610 |
Why?
| | Biology | 1 | 2021 | 88 | 0.610 |
Why?
| | Biomechanical Phenomena | 17 | 2025 | 857 | 0.610 |
Why?
| | Skull | 4 | 2014 | 162 | 0.610 |
Why?
| | Cell Communication | 3 | 2019 | 328 | 0.600 |
Why?
| | Small Molecule Libraries | 2 | 2011 | 111 | 0.590 |
Why?
| | Nanocomposites | 2 | 2009 | 14 | 0.590 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2022 | 273 | 0.580 |
Why?
| | Fibrinogen | 2 | 2025 | 180 | 0.580 |
Why?
| | Polyphenols | 1 | 2018 | 21 | 0.560 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 189 | 0.560 |
Why?
| | RNAi Therapeutics | 1 | 2018 | 7 | 0.560 |
Why?
| | Alginates | 3 | 2016 | 60 | 0.540 |
Why?
| | Peptide Hydrolases | 2 | 2018 | 105 | 0.540 |
Why?
| | Biodegradation, Environmental | 5 | 2012 | 75 | 0.540 |
Why?
| | Phosphoproteins | 3 | 2017 | 337 | 0.540 |
Why?
| | Azo Compounds | 1 | 2018 | 30 | 0.540 |
Why?
| | Musculoskeletal System | 1 | 2018 | 53 | 0.520 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2017 | 425 | 0.520 |
Why?
| | Caprolactam | 1 | 2017 | 3 | 0.510 |
Why?
| | Myocytes, Cardiac | 7 | 2026 | 546 | 0.510 |
Why?
| | Transfection | 3 | 2016 | 926 | 0.490 |
Why?
| | Liver Cirrhosis | 2 | 2016 | 287 | 0.490 |
Why?
| | Models, Cardiovascular | 6 | 2017 | 196 | 0.480 |
Why?
| | Microscopy, Atomic Force | 5 | 2019 | 128 | 0.470 |
Why?
| | Cell Line | 11 | 2023 | 2823 | 0.470 |
Why?
| | Microscopy, Electron, Scanning | 9 | 2013 | 196 | 0.460 |
Why?
| | Gene Silencing | 1 | 2016 | 202 | 0.460 |
Why?
| | Shear Strength | 2 | 2015 | 73 | 0.460 |
Why?
| | Organoids | 3 | 2022 | 145 | 0.460 |
Why?
| | Molecular Imprinting | 2 | 2015 | 5 | 0.460 |
Why?
| | Intercellular Signaling Peptides and Proteins | 5 | 2019 | 376 | 0.460 |
Why?
| | Surface Properties | 10 | 2018 | 386 | 0.450 |
Why?
| | Disease Models, Animal | 19 | 2021 | 4560 | 0.450 |
Why?
| | Chemotaxis | 2 | 2012 | 122 | 0.450 |
Why?
| | Bone Regeneration | 1 | 2015 | 27 | 0.450 |
Why?
| | Polymethacrylic Acids | 2 | 2013 | 61 | 0.440 |
Why?
| | Acrylic Resins | 3 | 2025 | 46 | 0.440 |
Why?
| | RNA Interference | 1 | 2016 | 475 | 0.430 |
Why?
| | Magnetics | 1 | 2014 | 46 | 0.430 |
Why?
| | Genetic Therapy | 1 | 2016 | 316 | 0.420 |
Why?
| | Maleimides | 1 | 2014 | 21 | 0.420 |
Why?
| | Tibial Meniscus Injuries | 1 | 2015 | 62 | 0.420 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2014 | 17 | 0.410 |
Why?
| | Bone Marrow Cells | 2 | 2012 | 321 | 0.410 |
Why?
| | Microfluidics | 5 | 2017 | 61 | 0.410 |
Why?
| | Skin | 3 | 2024 | 753 | 0.400 |
Why?
| | Compressive Strength | 6 | 2016 | 72 | 0.400 |
Why?
| | Biomedical Engineering | 4 | 2021 | 30 | 0.400 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 170 | 0.400 |
Why?
| | Finite Element Analysis | 8 | 2018 | 67 | 0.400 |
Why?
| | Immunosuppressive Agents | 5 | 2004 | 838 | 0.390 |
Why?
| | Molecular Structure | 6 | 2013 | 486 | 0.390 |
Why?
| | Rats, Wistar | 7 | 2019 | 450 | 0.380 |
Why?
| | Nanostructures | 3 | 2015 | 105 | 0.380 |
Why?
| | Transcription Factors | 4 | 2021 | 1734 | 0.380 |
Why?
| | Bone Substitutes | 2 | 2003 | 26 | 0.380 |
Why?
| | Proteins | 1 | 2019 | 1023 | 0.380 |
Why?
| | Substantia Nigra | 2 | 2024 | 63 | 0.370 |
Why?
| | Extracellular Matrix Proteins | 3 | 2013 | 156 | 0.370 |
Why?
| | Hemodynamics | 5 | 2019 | 1118 | 0.370 |
Why?
| | Time Factors | 17 | 2019 | 7123 | 0.370 |
Why?
| | Wound Healing | 4 | 2023 | 355 | 0.360 |
Why?
| | Stem Cell Niche | 1 | 2012 | 57 | 0.360 |
Why?
| | Bioreactors | 3 | 2025 | 50 | 0.360 |
Why?
| | Nerve Regeneration | 2 | 2009 | 58 | 0.350 |
Why?
| | Myocardial Contraction | 4 | 2018 | 293 | 0.350 |
Why?
| | Computer Simulation | 8 | 2021 | 1003 | 0.340 |
Why?
| | Calmodulin | 1 | 2011 | 70 | 0.340 |
Why?
| | Chondroitin Sulfates | 2 | 2009 | 35 | 0.340 |
Why?
| | Aorta | 2 | 2011 | 440 | 0.330 |
Why?
| | Gold | 4 | 2021 | 116 | 0.330 |
Why?
| | Mice, Nude | 6 | 2018 | 679 | 0.320 |
Why?
| | Biophysics | 2 | 2022 | 75 | 0.320 |
Why?
| | Hypertrophy | 1 | 2011 | 128 | 0.320 |
Why?
| | Polyesters | 8 | 2009 | 75 | 0.320 |
Why?
| | Fibrocartilage | 2 | 2025 | 7 | 0.320 |
Why?
| | Sheep | 7 | 2023 | 876 | 0.320 |
Why?
| | Male | 45 | 2026 | 72842 | 0.310 |
Why?
| | Hexuronic Acids | 3 | 2016 | 29 | 0.300 |
Why?
| | Membranes, Artificial | 1 | 2010 | 68 | 0.300 |
Why?
| | Glucuronic Acid | 3 | 2016 | 30 | 0.300 |
Why?
| | Kidney Diseases | 2 | 2013 | 425 | 0.300 |
Why?
| | Ultraviolet Rays | 6 | 2024 | 384 | 0.300 |
Why?
| | Human Umbilical Vein Endothelial Cells | 4 | 2019 | 104 | 0.300 |
Why?
| | Immunotherapy | 2 | 2015 | 666 | 0.290 |
Why?
| | Cell- and Tissue-Based Therapy | 3 | 2016 | 78 | 0.290 |
Why?
| | Biomimetics | 4 | 2021 | 41 | 0.290 |
Why?
| | Gelatin | 3 | 2021 | 56 | 0.280 |
Why?
| | Axons | 3 | 2024 | 204 | 0.280 |
Why?
| | Ear Auricle | 1 | 2008 | 14 | 0.280 |
Why?
| | Bioprosthesis | 1 | 2008 | 39 | 0.270 |
Why?
| | Transplantation | 1 | 2008 | 33 | 0.270 |
Why?
| | Myocardial Ischemia | 3 | 2015 | 285 | 0.260 |
Why?
| | Inflammation | 4 | 2016 | 2878 | 0.260 |
Why?
| | Implants, Experimental | 3 | 2013 | 21 | 0.260 |
Why?
| | Molecular Weight | 4 | 2009 | 312 | 0.260 |
Why?
| | Bioengineering | 2 | 2019 | 20 | 0.250 |
Why?
| | Focal Adhesions | 3 | 2018 | 47 | 0.250 |
Why?
| | Neurogenesis | 1 | 2009 | 157 | 0.250 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2018 | 36 | 0.250 |
Why?
| | Mitral Valve Insufficiency | 2 | 2019 | 68 | 0.250 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2018 | 117 | 0.250 |
Why?
| | Lymphocytes | 2 | 1999 | 376 | 0.250 |
Why?
| | Ear Cartilage | 1 | 2006 | 4 | 0.250 |
Why?
| | Electrochemistry | 4 | 2011 | 70 | 0.250 |
Why?
| | Anisotropy | 7 | 2025 | 73 | 0.250 |
Why?
| | Recovery of Function | 8 | 2026 | 716 | 0.250 |
Why?
| | Waiting Lists | 3 | 2008 | 266 | 0.250 |
Why?
| | Prostheses and Implants | 3 | 2019 | 137 | 0.250 |
Why?
| | Doxorubicin | 1 | 2009 | 401 | 0.240 |
Why?
| | Streptavidin | 1 | 2026 | 15 | 0.240 |
Why?
| | Norbornanes | 3 | 2024 | 15 | 0.240 |
Why?
| | Viscosity | 3 | 2018 | 92 | 0.240 |
Why?
| | Collagenases | 2 | 2017 | 22 | 0.240 |
Why?
| | Cell Proliferation | 10 | 2019 | 2507 | 0.240 |
Why?
| | Kinetics | 5 | 2021 | 1567 | 0.240 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 956 | 0.240 |
Why?
| | Glioblastoma | 2 | 2021 | 353 | 0.230 |
Why?
| | Heart | 3 | 2016 | 626 | 0.230 |
Why?
| | Liquid Crystals | 1 | 2026 | 28 | 0.230 |
Why?
| | Growth Substances | 2 | 2003 | 138 | 0.230 |
Why?
| | Kidney | 5 | 2025 | 1497 | 0.230 |
Why?
| | Cell Enlargement | 1 | 2005 | 8 | 0.230 |
Why?
| | Collagen Type V | 1 | 2025 | 4 | 0.230 |
Why?
| | Diastole | 2 | 2016 | 146 | 0.230 |
Why?
| | Drug Compounding | 5 | 2018 | 107 | 0.220 |
Why?
| | Neurites | 1 | 2005 | 50 | 0.220 |
Why?
| | Temperature | 4 | 2011 | 633 | 0.220 |
Why?
| | Durapatite | 3 | 2014 | 37 | 0.220 |
Why?
| | 3T3 Cells | 3 | 2018 | 156 | 0.220 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 121 | 0.220 |
Why?
| | Cells, Immobilized | 3 | 2016 | 20 | 0.210 |
Why?
| | Flow Cytometry | 3 | 2019 | 1162 | 0.210 |
Why?
| | Calcification, Physiologic | 2 | 2013 | 29 | 0.210 |
Why?
| | Biomedical Research | 1 | 2011 | 717 | 0.210 |
Why?
| | Elasticity | 4 | 2010 | 189 | 0.210 |
Why?
| | Emulsions | 2 | 2022 | 59 | 0.210 |
Why?
| | Bone Marrow Transplantation | 2 | 2018 | 298 | 0.210 |
Why?
| | Goats | 1 | 2023 | 18 | 0.200 |
Why?
| | Interleukin-1beta | 1 | 2026 | 389 | 0.200 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 3 | 2015 | 192 | 0.200 |
Why?
| | Dopaminergic Neurons | 1 | 2024 | 68 | 0.200 |
Why?
| | Immunohistochemistry | 5 | 2014 | 1716 | 0.200 |
Why?
| | Azetidines | 1 | 2024 | 45 | 0.200 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2023 | 20 | 0.200 |
Why?
| | Intervertebral Disc | 1 | 2023 | 36 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2022 | 104 | 0.200 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 33 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2026 | 247 | 0.200 |
Why?
| | Proteolysis | 2 | 2015 | 172 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 8 | 2016 | 3904 | 0.200 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2026 | 196 | 0.190 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 120 | 0.190 |
Why?
| | Butadienes | 1 | 2003 | 33 | 0.190 |
Why?
| | Glass | 2 | 2016 | 46 | 0.190 |
Why?
| | Corpus Striatum | 1 | 2024 | 179 | 0.190 |
Why?
| | Cues | 2 | 2022 | 327 | 0.190 |
Why?
| | Purines | 1 | 2024 | 187 | 0.190 |
Why?
| | Alkaline Phosphatase | 4 | 2013 | 144 | 0.180 |
Why?
| | Technology | 1 | 2023 | 97 | 0.180 |
Why?
| | Recombinant Proteins | 3 | 2018 | 1368 | 0.180 |
Why?
| | Thermodynamics | 3 | 2021 | 419 | 0.180 |
Why?
| | Polyhydroxyethyl Methacrylate | 2 | 2013 | 10 | 0.180 |
Why?
| | Mice, Inbred BALB C | 4 | 2015 | 1261 | 0.180 |
Why?
| | Hydrazones | 1 | 2022 | 26 | 0.180 |
Why?
| | Hydrazines | 1 | 2022 | 37 | 0.180 |
Why?
| | Pentoxifylline | 2 | 1999 | 23 | 0.180 |
Why?
| | Baths | 1 | 2021 | 14 | 0.180 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2012 | 59 | 0.170 |
Why?
| | Models, Biological | 4 | 2018 | 1764 | 0.170 |
Why?
| | Biliary Atresia | 1 | 2023 | 158 | 0.170 |
Why?
| | Neostriatum | 1 | 2021 | 37 | 0.170 |
Why?
| | Aldehydes | 1 | 2022 | 139 | 0.170 |
Why?
| | Green Fluorescent Proteins | 3 | 2018 | 407 | 0.170 |
Why?
| | Models, Animal | 4 | 2021 | 393 | 0.160 |
Why?
| | Drug Implants | 2 | 2015 | 83 | 0.160 |
Why?
| | Nerve Fibers | 1 | 2021 | 105 | 0.160 |
Why?
| | Apoptosis | 2 | 2013 | 2440 | 0.160 |
Why?
| | Drug Liberation | 2 | 2018 | 36 | 0.160 |
Why?
| | Aggrecans | 2 | 2011 | 15 | 0.160 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2883 | 0.160 |
Why?
| | Collagen Type II | 2 | 2011 | 53 | 0.160 |
Why?
| | Metal Nanoparticles | 1 | 2021 | 80 | 0.160 |
Why?
| | Chickens | 2 | 2011 | 179 | 0.160 |
Why?
| | Fibrosis | 6 | 2020 | 559 | 0.160 |
Why?
| | Polysaccharides | 1 | 2020 | 86 | 0.160 |
Why?
| | Cyclodextrins | 2 | 2021 | 11 | 0.160 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 196 | 0.160 |
Why?
| | In Vitro Techniques | 3 | 2015 | 1048 | 0.160 |
Why?
| | Disease | 1 | 2021 | 96 | 0.160 |
Why?
| | Cartilage Diseases | 1 | 2020 | 45 | 0.160 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 82 | 0.150 |
Why?
| | Acrylates | 2 | 2011 | 48 | 0.150 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 408 | 0.150 |
Why?
| | Pyrazoles | 1 | 2024 | 517 | 0.150 |
Why?
| | Sulfonamides | 1 | 2024 | 583 | 0.150 |
Why?
| | Collagen Type I | 2 | 2011 | 143 | 0.150 |
Why?
| | Heart-Assist Devices | 1 | 2026 | 568 | 0.150 |
Why?
| | Pyrrolidinones | 1 | 1999 | 29 | 0.150 |
Why?
| | Macrophages | 3 | 2014 | 1507 | 0.150 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 348 | 0.150 |
Why?
| | Acyltransferases | 2 | 2017 | 78 | 0.150 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1999 | 73 | 0.150 |
Why?
| | Gene Expression Regulation | 4 | 2013 | 2597 | 0.150 |
Why?
| | Mitral Valve | 1 | 2019 | 95 | 0.140 |
Why?
| | Anhydrides | 3 | 2005 | 19 | 0.140 |
Why?
| | Matrix Metalloproteinases | 2 | 2022 | 95 | 0.140 |
Why?
| | Proteomics | 1 | 2025 | 1188 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2009 | 156 | 0.140 |
Why?
| | Swine, Miniature | 2 | 2015 | 89 | 0.140 |
Why?
| | Angiogenic Proteins | 1 | 2018 | 15 | 0.140 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2018 | 56 | 0.140 |
Why?
| | Terminology as Topic | 2 | 2017 | 257 | 0.140 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 385 | 0.140 |
Why?
| | Drug Synergism | 2 | 2015 | 354 | 0.140 |
Why?
| | Dextran Sulfate | 1 | 2018 | 93 | 0.140 |
Why?
| | Chromatin | 1 | 2022 | 553 | 0.140 |
Why?
| | Polyglycolic Acid | 4 | 2010 | 44 | 0.140 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2018 | 81 | 0.140 |
Why?
| | Isomerism | 1 | 2018 | 56 | 0.140 |
Why?
| | Cell Shape | 2 | 2016 | 56 | 0.140 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2018 | 2028 | 0.140 |
Why?
| | Connective Tissue Cells | 1 | 2017 | 2 | 0.140 |
Why?
| | Tacrolimus | 4 | 2004 | 196 | 0.130 |
Why?
| | Serum Albumin, Bovine | 1 | 2018 | 62 | 0.130 |
Why?
| | Prions | 1 | 2018 | 56 | 0.130 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2017 | 85 | 0.130 |
Why?
| | Spectrophotometry, Ultraviolet | 3 | 2009 | 81 | 0.130 |
Why?
| | Molecular Probes | 1 | 2017 | 33 | 0.130 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2025 | 17 | 0.130 |
Why?
| | Stromal Cells | 1 | 2018 | 121 | 0.130 |
Why?
| | Rats, Nude | 1 | 2017 | 25 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2009 | 627 | 0.130 |
Why?
| | Photolysis | 2 | 2025 | 90 | 0.130 |
Why?
| | Cell-Derived Microparticles | 1 | 2018 | 73 | 0.130 |
Why?
| | Blood Platelets | 1 | 2020 | 379 | 0.130 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2129 | 0.130 |
Why?
| | Cyclosporine | 5 | 2004 | 256 | 0.130 |
Why?
| | Excitation Contraction Coupling | 1 | 2016 | 13 | 0.120 |
Why?
| | Adenocarcinoma | 2 | 2023 | 925 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2019 | 251 | 0.120 |
Why?
| | Kidney Transplantation | 6 | 2000 | 712 | 0.120 |
Why?
| | Cardiovascular Agents | 1 | 2018 | 166 | 0.120 |
Why?
| | Treatment Outcome | 7 | 2015 | 11772 | 0.120 |
Why?
| | Hydrolysis | 2 | 2026 | 197 | 0.120 |
Why?
| | Pericardium | 1 | 2017 | 59 | 0.120 |
Why?
| | Cell Aggregation | 1 | 2016 | 19 | 0.120 |
Why?
| | Cardiac Volume | 2 | 2017 | 14 | 0.120 |
Why?
| | Hardness | 1 | 2016 | 17 | 0.120 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 207 | 0.120 |
Why?
| | Embryonic Stem Cells | 2 | 2007 | 124 | 0.120 |
Why?
| | Remission, Spontaneous | 1 | 2016 | 39 | 0.120 |
Why?
| | Neurotrophin 3 | 2 | 2006 | 10 | 0.120 |
Why?
| | Bioartificial Organs | 1 | 2016 | 3 | 0.120 |
Why?
| | Liposomes | 2 | 2026 | 262 | 0.120 |
Why?
| | Heart Conduction System | 1 | 2016 | 96 | 0.120 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 679 | 0.120 |
Why?
| | Adhesiveness | 2 | 2013 | 18 | 0.120 |
Why?
| | Calixarenes | 1 | 2015 | 5 | 0.120 |
Why?
| | Dermis | 1 | 2015 | 31 | 0.120 |
Why?
| | Macrocyclic Compounds | 1 | 2015 | 15 | 0.120 |
Why?
| | Bridged-Ring Compounds | 1 | 2015 | 31 | 0.120 |
Why?
| | Hindlimb | 2 | 2015 | 132 | 0.110 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2015 | 50 | 0.110 |
Why?
| | Fibrin | 1 | 2016 | 84 | 0.110 |
Why?
| | Sensation | 1 | 2015 | 55 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1996 | 0.110 |
Why?
| | Gene Transfer Techniques | 1 | 2016 | 187 | 0.110 |
Why?
| | Enzyme Therapy | 1 | 2015 | 4 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2015 | 124 | 0.110 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 187 | 0.110 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2015 | 13 | 0.110 |
Why?
| | Radiography | 2 | 2014 | 852 | 0.110 |
Why?
| | Blood Vessel Prosthesis | 2 | 2013 | 140 | 0.110 |
Why?
| | Phenols | 1 | 2015 | 106 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 699 | 0.110 |
Why?
| | Parkinson Disease | 1 | 2021 | 599 | 0.110 |
Why?
| | Glycosaminoglycans | 2 | 2012 | 79 | 0.110 |
Why?
| | DNA | 3 | 2009 | 1435 | 0.110 |
Why?
| | Ventricular Function | 1 | 2014 | 53 | 0.110 |
Why?
| | Weight-Bearing | 2 | 2013 | 183 | 0.110 |
Why?
| | Spinal Cord | 2 | 2015 | 382 | 0.110 |
Why?
| | Bone Remodeling | 1 | 2014 | 71 | 0.100 |
Why?
| | Menisci, Tibial | 1 | 2015 | 78 | 0.100 |
Why?
| | Technology, Pharmaceutical | 1 | 2014 | 30 | 0.100 |
Why?
| | Immune Tolerance | 1 | 2017 | 385 | 0.100 |
Why?
| | Fracture Healing | 1 | 2014 | 91 | 0.100 |
Why?
| | Imidazoles | 1 | 2015 | 247 | 0.100 |
Why?
| | Posture | 1 | 2015 | 197 | 0.100 |
Why?
| | Cardiomyopathies | 2 | 2017 | 335 | 0.100 |
Why?
| | Graft Survival | 5 | 2018 | 518 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2018 | 447 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2016 | 286 | 0.100 |
Why?
| | Injections, Intradermal | 1 | 2013 | 11 | 0.100 |
Why?
| | Lung | 3 | 2023 | 4106 | 0.100 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2014 | 112 | 0.100 |
Why?
| | Neuregulin-1 | 1 | 2014 | 49 | 0.100 |
Why?
| | Glucocorticoids | 1 | 1998 | 531 | 0.100 |
Why?
| | Solubility | 1 | 2014 | 240 | 0.100 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 409 | 0.100 |
Why?
| | Vinculin | 1 | 2013 | 10 | 0.100 |
Why?
| | Molecular Mimicry | 1 | 2013 | 36 | 0.100 |
Why?
| | Prosthesis Design | 1 | 2015 | 354 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2769 | 0.100 |
Why?
| | Nanoparticles | 2 | 2010 | 517 | 0.100 |
Why?
| | Osseointegration | 1 | 2013 | 59 | 0.100 |
Why?
| | Reperfusion Injury | 1 | 2016 | 293 | 0.100 |
Why?
| | Graft Rejection | 5 | 2000 | 521 | 0.090 |
Why?
| | Phenotype | 5 | 2025 | 3155 | 0.090 |
Why?
| | Receptors, Notch | 1 | 2013 | 90 | 0.090 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 177 | 0.090 |
Why?
| | PPAR gamma | 1 | 2013 | 178 | 0.090 |
Why?
| | Echocardiography | 2 | 2016 | 647 | 0.090 |
Why?
| | Coculture Techniques | 3 | 2019 | 247 | 0.090 |
Why?
| | Nerve Net | 1 | 2015 | 284 | 0.090 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2012 | 552 | 0.090 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 474 | 0.090 |
Why?
| | Static Electricity | 1 | 2012 | 114 | 0.090 |
Why?
| | Biological Products | 1 | 2016 | 257 | 0.090 |
Why?
| | Heart Failure | 1 | 2026 | 2326 | 0.090 |
Why?
| | Cardiac Output | 2 | 2011 | 179 | 0.090 |
Why?
| | Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2011 | 2 | 0.090 |
Why?
| | Methylmethacrylates | 1 | 2011 | 3 | 0.090 |
Why?
| | Transition Temperature | 1 | 2011 | 28 | 0.090 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 221 | 0.090 |
Why?
| | P-Selectin | 1 | 2011 | 29 | 0.090 |
Why?
| | Myocardial Reperfusion | 1 | 2011 | 56 | 0.090 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2011 | 25 | 0.090 |
Why?
| | Cell Polarity | 1 | 2012 | 137 | 0.090 |
Why?
| | Injections, Intralesional | 2 | 2025 | 35 | 0.080 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 477 | 0.080 |
Why?
| | Acrylamides | 1 | 2011 | 74 | 0.080 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 85 | 0.080 |
Why?
| | A Kinase Anchor Proteins | 1 | 2011 | 70 | 0.080 |
Why?
| | Tissue Culture Techniques | 1 | 2011 | 82 | 0.080 |
Why?
| | Protein Engineering | 1 | 2011 | 122 | 0.080 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2011 | 71 | 0.080 |
Why?
| | Models, Chemical | 2 | 2002 | 250 | 0.080 |
Why?
| | Polymerization | 1 | 2011 | 127 | 0.080 |
Why?
| | Micelles | 1 | 2010 | 39 | 0.080 |
Why?
| | Random Allocation | 2 | 2025 | 365 | 0.080 |
Why?
| | Cell Division | 2 | 2004 | 756 | 0.080 |
Why?
| | Glycolates | 2 | 2010 | 6 | 0.080 |
Why?
| | Pressure | 1 | 2010 | 226 | 0.080 |
Why?
| | Microvessels | 1 | 2011 | 97 | 0.080 |
Why?
| | Molecular Conformation | 1 | 2010 | 141 | 0.080 |
Why?
| | Macromolecular Substances | 1 | 2010 | 216 | 0.080 |
Why?
| | Chitosan | 2 | 2007 | 39 | 0.080 |
Why?
| | Coronary Vessels | 1 | 2011 | 246 | 0.070 |
Why?
| | Ethylene Glycols | 1 | 2009 | 17 | 0.070 |
Why?
| | Microscopy | 1 | 2010 | 147 | 0.070 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2009 | 14 | 0.070 |
Why?
| | Morphogenesis | 2 | 2025 | 172 | 0.070 |
Why?
| | Absorption | 1 | 2009 | 60 | 0.070 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2009 | 79 | 0.070 |
Why?
| | High-Throughput Screening Assays | 1 | 2011 | 176 | 0.070 |
Why?
| | Methylprednisolone | 2 | 1999 | 59 | 0.070 |
Why?
| | Lactates | 2 | 2005 | 82 | 0.070 |
Why?
| | Mesoderm | 1 | 2009 | 147 | 0.070 |
Why?
| | Histones | 2 | 2025 | 666 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2187 | 0.070 |
Why?
| | Peripheral Nerves | 1 | 2009 | 72 | 0.070 |
Why?
| | Sheep, Domestic | 2 | 2019 | 34 | 0.070 |
Why?
| | Stroke Volume | 2 | 2025 | 654 | 0.070 |
Why?
| | Pyrroles | 1 | 2009 | 220 | 0.070 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2008 | 7 | 0.070 |
Why?
| | Surface-Active Agents | 1 | 2009 | 98 | 0.070 |
Why?
| | Metals | 1 | 2009 | 136 | 0.070 |
Why?
| | Asia | 1 | 2008 | 70 | 0.070 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 668 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 910 | 0.070 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 319 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2016 | 875 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3542 | 0.070 |
Why?
| | Immunoenzyme Techniques | 1 | 2008 | 200 | 0.070 |
Why?
| | Propylene Glycols | 1 | 2007 | 28 | 0.070 |
Why?
| | Organ Specificity | 1 | 2008 | 309 | 0.070 |
Why?
| | Equipment Design | 1 | 2009 | 525 | 0.070 |
Why?
| | Geography | 1 | 2008 | 187 | 0.060 |
Why?
| | Adult | 11 | 2021 | 40777 | 0.060 |
Why?
| | Muscle Cells | 1 | 2007 | 41 | 0.060 |
Why?
| | Travel | 1 | 2008 | 136 | 0.060 |
Why?
| | Ventricular Pressure | 2 | 2018 | 52 | 0.060 |
Why?
| | Kidney Function Tests | 2 | 2016 | 156 | 0.060 |
Why?
| | Membrane Proteins | 1 | 2013 | 1164 | 0.060 |
Why?
| | Ligands | 2 | 2021 | 665 | 0.060 |
Why?
| | Neurons | 3 | 2021 | 1649 | 0.060 |
Why?
| | Biotin | 1 | 2026 | 32 | 0.060 |
Why?
| | Cell Count | 3 | 2013 | 319 | 0.060 |
Why?
| | Bone Marrow | 1 | 2008 | 306 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 574 | 0.060 |
Why?
| | Organotechnetium Compounds | 1 | 2025 | 12 | 0.060 |
Why?
| | Hot Temperature | 1 | 2009 | 396 | 0.060 |
Why?
| | Adipates | 1 | 2005 | 4 | 0.060 |
Why?
| | Ethylamines | 1 | 2005 | 5 | 0.060 |
Why?
| | Integrin alphaVbeta3 | 1 | 2025 | 20 | 0.060 |
Why?
| | Single Photon Emission Computed Tomography Computed Tomography | 1 | 2025 | 14 | 0.060 |
Why?
| | Ciliary Neurotrophic Factor | 1 | 2005 | 12 | 0.060 |
Why?
| | Decanoic Acids | 1 | 2005 | 12 | 0.060 |
Why?
| | Cardiac Imaging Techniques | 1 | 2025 | 24 | 0.060 |
Why?
| | Muscles | 2 | 2001 | 330 | 0.060 |
Why?
| | Erythroblasts | 1 | 2005 | 18 | 0.060 |
Why?
| | Tissue and Organ Procurement | 2 | 2008 | 343 | 0.060 |
Why?
| | Hydroxamic Acids | 1 | 2025 | 94 | 0.060 |
Why?
| | Animals, Newborn | 2 | 2014 | 891 | 0.060 |
Why?
| | Polyanhydrides | 1 | 2005 | 2 | 0.060 |
Why?
| | Carbohydrate Sequence | 1 | 2005 | 29 | 0.060 |
Why?
| | Cohort Studies | 2 | 2010 | 6013 | 0.050 |
Why?
| | Lipids | 1 | 2010 | 707 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2018 | 741 | 0.050 |
Why?
| | Organogenesis | 1 | 2025 | 63 | 0.050 |
Why?
| | Acetylation | 1 | 2025 | 259 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2025 | 108 | 0.050 |
Why?
| | Cardiac Surgical Procedures | 1 | 2010 | 610 | 0.050 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2005 | 154 | 0.050 |
Why?
| | Nucleus Pulposus | 1 | 2023 | 1 | 0.050 |
Why?
| | Spectrometry, Fluorescence | 1 | 2004 | 165 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2188 | 0.050 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 28 | 0.050 |
Why?
| | Female | 14 | 2026 | 78844 | 0.050 |
Why?
| | Cell Separation | 1 | 2004 | 305 | 0.050 |
Why?
| | Myoblasts | 1 | 2023 | 83 | 0.050 |
Why?
| | Bilirubin | 1 | 2023 | 99 | 0.050 |
Why?
| | Transcriptome | 2 | 2021 | 1038 | 0.050 |
Why?
| | Chromatography, Gel | 1 | 2003 | 130 | 0.050 |
Why?
| | Psoriasis | 1 | 2024 | 115 | 0.050 |
Why?
| | Retina | 1 | 2005 | 326 | 0.050 |
Why?
| | Connective Tissue | 1 | 2022 | 38 | 0.050 |
Why?
| | Rabbits | 1 | 2023 | 652 | 0.050 |
Why?
| | Tissue Donors | 2 | 1997 | 420 | 0.050 |
Why?
| | Spinal Cord Injuries | 1 | 2006 | 234 | 0.050 |
Why?
| | Biosensing Techniques | 1 | 2004 | 142 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 206 | 0.050 |
Why?
| | Perfusion | 1 | 2023 | 251 | 0.050 |
Why?
| | Theranostic Nanomedicine | 1 | 2022 | 15 | 0.040 |
Why?
| | Liver Transplantation | 3 | 1995 | 826 | 0.040 |
Why?
| | Sirolimus | 1 | 2004 | 280 | 0.040 |
Why?
| | Dopamine | 1 | 2024 | 295 | 0.040 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 26 | 0.040 |
Why?
| | Middle Aged | 9 | 2026 | 36215 | 0.040 |
Why?
| | Tendons | 1 | 2023 | 131 | 0.040 |
Why?
| | Cholic Acid | 1 | 2021 | 4 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2003 | 563 | 0.040 |
Why?
| | Aspergillus fumigatus | 1 | 2001 | 26 | 0.040 |
Why?
| | Aged | 5 | 2026 | 26153 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2022 | 192 | 0.040 |
Why?
| | Photochemotherapy | 1 | 2001 | 39 | 0.040 |
Why?
| | Chlorobenzenes | 1 | 2001 | 18 | 0.040 |
Why?
| | Succinimides | 1 | 2001 | 21 | 0.040 |
Why?
| | Cell Cycle Proteins | 2 | 2017 | 630 | 0.040 |
Why?
| | Polystyrenes | 1 | 2001 | 38 | 0.040 |
Why?
| | Fluorescent Dyes | 2 | 2015 | 333 | 0.040 |
Why?
| | Optical Imaging | 1 | 2021 | 61 | 0.040 |
Why?
| | Plasmapheresis | 1 | 2000 | 24 | 0.040 |
Why?
| | Cell Engineering | 1 | 2020 | 15 | 0.040 |
Why?
| | Contrast Media | 1 | 2023 | 497 | 0.040 |
Why?
| | Adsorption | 1 | 2001 | 153 | 0.040 |
Why?
| | Nuclear Envelope | 1 | 2021 | 45 | 0.040 |
Why?
| | Epigenomics | 1 | 2021 | 114 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2020 | 108 | 0.040 |
Why?
| | Kidney Glomerulus | 2 | 1998 | 125 | 0.040 |
Why?
| | Cryopreservation | 1 | 2021 | 113 | 0.040 |
Why?
| | Fibronectins | 1 | 2020 | 136 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2004 | 1132 | 0.040 |
Why?
| | Rolipram | 1 | 1999 | 4 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2000 | 133 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 506 | 0.040 |
Why?
| | Tritium | 1 | 1999 | 67 | 0.040 |
Why?
| | Thymidine | 1 | 1999 | 60 | 0.040 |
Why?
| | Neural Pathways | 1 | 2021 | 313 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2023 | 734 | 0.040 |
Why?
| | Nephrectomy | 1 | 2000 | 163 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 265 | 0.040 |
Why?
| | Registries | 1 | 2008 | 2406 | 0.040 |
Why?
| | Biopsy | 3 | 2016 | 1082 | 0.040 |
Why?
| | Cathelicidins | 1 | 2018 | 40 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 804 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2016 | 5983 | 0.040 |
Why?
| | beta Karyopherins | 1 | 2018 | 9 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2019 | 247 | 0.030 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 1998 | 41 | 0.030 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2018 | 21 | 0.030 |
Why?
| | RNA-Binding Protein EWS | 1 | 2018 | 31 | 0.030 |
Why?
| | Prednisolone | 1 | 1998 | 67 | 0.030 |
Why?
| | Karyopherins | 1 | 2018 | 20 | 0.030 |
Why?
| | Living Donors | 1 | 2000 | 282 | 0.030 |
Why?
| | Systole | 1 | 2018 | 181 | 0.030 |
Why?
| | Paracrine Communication | 1 | 2018 | 67 | 0.030 |
Why?
| | Cell Size | 1 | 2018 | 92 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2018 | 147 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 362 | 0.030 |
Why?
| | Integrins | 1 | 2018 | 90 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2017 | 69 | 0.030 |
Why?
| | Stress Fibers | 1 | 2017 | 18 | 0.030 |
Why?
| | Cytoplasm | 1 | 2018 | 254 | 0.030 |
Why?
| | Actomyosin | 1 | 2017 | 20 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 67 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 779 | 0.030 |
Why?
| | Health Care Rationing | 1 | 1997 | 56 | 0.030 |
Why?
| | HeLa Cells | 1 | 2018 | 632 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 311 | 0.030 |
Why?
| | Molecular Chaperones | 1 | 2018 | 199 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 506 | 0.030 |
Why?
| | Sus scrofa | 1 | 2016 | 65 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2018 | 237 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 142 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1999 | 784 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 242 | 0.030 |
Why?
| | Acidosis, Renal Tubular | 1 | 1995 | 4 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2016 | 80 | 0.030 |
Why?
| | Laparoscopy | 1 | 2000 | 481 | 0.030 |
Why?
| | Capsules | 1 | 2015 | 42 | 0.030 |
Why?
| | Oxazines | 1 | 2015 | 37 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1998 | 1300 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2015 | 168 | 0.030 |
Why?
| | Dextrans | 1 | 2015 | 84 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 156 | 0.030 |
Why?
| | Trans-Activators | 1 | 2017 | 396 | 0.030 |
Why?
| | Databases, Factual | 1 | 2001 | 1490 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 115 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 277 | 0.030 |
Why?
| | Kidney Tubules, Proximal | 1 | 1995 | 130 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1149 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 456 | 0.030 |
Why?
| | Venous Cutdown | 1 | 1994 | 1 | 0.030 |
Why?
| | Behavior, Animal | 2 | 2009 | 519 | 0.030 |
Why?
| | Homeostasis | 1 | 2018 | 642 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2015 | 531 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2013 | 27 | 0.020 |
Why?
| | Attitude to Health | 1 | 1997 | 430 | 0.020 |
Why?
| | Jagged-1 Protein | 1 | 2013 | 22 | 0.020 |
Why?
| | Immobilized Proteins | 1 | 2013 | 10 | 0.020 |
Why?
| | Catheters, Indwelling | 1 | 1994 | 96 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 95 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 48 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 2016 | 558 | 0.020 |
Why?
| | Lactones | 1 | 2012 | 59 | 0.020 |
Why?
| | Blood Pressure | 2 | 2016 | 1779 | 0.020 |
Why?
| | Creatinine | 3 | 2000 | 515 | 0.020 |
Why?
| | L-Selectin | 1 | 2011 | 27 | 0.020 |
Why?
| | Diffusion | 1 | 2012 | 120 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2018 | 1454 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2016 | 776 | 0.020 |
Why?
| | Fluorescence | 1 | 2012 | 159 | 0.020 |
Why?
| | Synapses | 1 | 2015 | 439 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1767 | 0.020 |
Why?
| | Cyclosporins | 1 | 1991 | 71 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2011 | 134 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1480 | 0.020 |
Why?
| | Hepatitis B | 1 | 1991 | 66 | 0.020 |
Why?
| | Surgical Mesh | 1 | 2010 | 50 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2011 | 300 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2011 | 319 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4295 | 0.020 |
Why?
| | United States | 1 | 2008 | 16098 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2864 | 0.020 |
Why?
| | Electric Conductivity | 1 | 2009 | 85 | 0.020 |
Why?
| | Fluorescein | 1 | 2009 | 24 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2009 | 62 | 0.020 |
Why?
| | Postoperative Complications | 2 | 2000 | 2970 | 0.020 |
Why?
| | Fetal Blood | 1 | 2011 | 327 | 0.020 |
Why?
| | Histocompatibility Testing | 2 | 2000 | 123 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 340 | 0.020 |
Why?
| | Biological Assay | 1 | 2009 | 130 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2011 | 394 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2011 | 435 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 845 | 0.020 |
Why?
| | Culture Media | 1 | 2007 | 161 | 0.020 |
Why?
| | Mutation | 1 | 2018 | 4075 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 34 | 0.020 |
Why?
| | Pregnancy Complications, Infectious | 1 | 1991 | 440 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2007 | 153 | 0.010 |
Why?
| | Macrophages, Peritoneal | 1 | 2006 | 89 | 0.010 |
Why?
| | Hypertension | 1 | 1995 | 1273 | 0.010 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2006 | 122 | 0.010 |
Why?
| | Acute Disease | 2 | 2000 | 1036 | 0.010 |
Why?
| | Child | 2 | 2023 | 22707 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2015 | 1789 | 0.010 |
Why?
| | Neuroglia | 1 | 2006 | 173 | 0.010 |
Why?
| | Actins | 1 | 2007 | 425 | 0.010 |
Why?
| | Body Fluids | 1 | 2005 | 71 | 0.010 |
Why?
| | Laminin | 1 | 2004 | 72 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2004 | 219 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2004 | 234 | 0.010 |
Why?
| | Particle Size | 1 | 2005 | 381 | 0.010 |
Why?
| | Motor Activity | 1 | 2006 | 718 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3413 | 0.010 |
Why?
| | Sequence Tagged Sites | 1 | 2001 | 7 | 0.010 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2001 | 21 | 0.010 |
Why?
| | Information Services | 1 | 2001 | 43 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 693 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2000 | 178 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 538 | 0.010 |
Why?
| | Antibody Formation | 1 | 2000 | 288 | 0.010 |
Why?
| | Cytokines | 1 | 2006 | 2067 | 0.010 |
Why?
| | Antibodies | 1 | 2000 | 397 | 0.010 |
Why?
| | Bone and Bones | 1 | 2000 | 317 | 0.010 |
Why?
| | Follow-Up Studies | 2 | 1998 | 5423 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1374 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 164 | 0.010 |
Why?
| | Lymphoproliferative Disorders | 1 | 1996 | 57 | 0.010 |
Why?
| | Thrombosis | 1 | 2000 | 400 | 0.010 |
Why?
| | Drug Resistance | 1 | 1996 | 145 | 0.010 |
Why?
| | Telephone | 1 | 1997 | 177 | 0.010 |
Why?
| | Internet | 1 | 2001 | 689 | 0.010 |
Why?
| | Diarrhea, Infantile | 1 | 1995 | 4 | 0.010 |
Why?
| | Cadaver | 1 | 1997 | 311 | 0.010 |
Why?
| | Blood Urea Nitrogen | 1 | 1995 | 53 | 0.010 |
Why?
| | Bicarbonates | 1 | 1995 | 45 | 0.010 |
Why?
| | Reperfusion | 1 | 1995 | 54 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 1996 | 206 | 0.010 |
Why?
| | Atrophy | 1 | 1995 | 199 | 0.010 |
Why?
| | Oxygenators | 1 | 1994 | 4 | 0.010 |
Why?
| | Axillary Vein | 1 | 1994 | 5 | 0.010 |
Why?
| | Central Venous Pressure | 1 | 1994 | 17 | 0.010 |
Why?
| | Kidney Tubules | 1 | 1995 | 118 | 0.010 |
Why?
| | Subclavian Vein | 1 | 1994 | 15 | 0.010 |
Why?
| | Fluid Therapy | 1 | 1995 | 155 | 0.010 |
Why?
| | Hepatic Artery | 1 | 1994 | 53 | 0.010 |
Why?
| | Jugular Veins | 1 | 1994 | 42 | 0.010 |
Why?
| | Femoral Vein | 1 | 1994 | 38 | 0.010 |
Why?
| | Triazines | 1 | 1974 | 49 | 0.010 |
Why?
| | Elbow | 1 | 1994 | 56 | 0.010 |
Why?
| | Veins | 1 | 1994 | 69 | 0.010 |
Why?
| | Vena Cava, Inferior | 1 | 1994 | 83 | 0.010 |
Why?
| | Incidence | 1 | 2000 | 2923 | 0.010 |
Why?
| | Interviews as Topic | 1 | 1997 | 910 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 866 | 0.010 |
Why?
| | Portal Vein | 1 | 1994 | 117 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 738 | 0.010 |
Why?
| | Catheterization, Central Venous | 1 | 1994 | 123 | 0.010 |
Why?
| | Health Status | 1 | 1997 | 832 | 0.010 |
Why?
| | Transplantation, Isogeneic | 1 | 1991 | 17 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1991 | 49 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1991 | 39 | 0.010 |
Why?
| | Rats, Inbred BN | 1 | 1991 | 56 | 0.010 |
Why?
| | Rats, Inbred Lew | 1 | 1991 | 105 | 0.010 |
Why?
| | Blood Transfusion | 1 | 1994 | 409 | 0.000 |
Why?
| | Major Histocompatibility Complex | 1 | 1991 | 233 | 0.000 |
Why?
| | Heart Rate | 1 | 1994 | 855 | 0.000 |
Why?
| | Kidney Neoplasms | 1 | 1974 | 413 | 0.000 |
Why?
| | Retrospective Studies | 2 | 2000 | 17291 | 0.000 |
Why?
| | Prevalence | 1 | 1995 | 2865 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1995 | 2953 | 0.000 |
Why?
| | Anesthesia | 1 | 1991 | 256 | 0.000 |
Why?
| | Risk Factors | 1 | 2000 | 10885 | 0.000 |
Why?
| | Quality of Life | 1 | 1997 | 3204 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1974 | 2214 | 0.000 |
Why?
| | Infant | 1 | 1995 | 10077 | 0.000 |
Why?
| | Adolescent | 1 | 1998 | 22529 | 0.000 |
Why?
| | Pregnancy | 1 | 1991 | 7202 | 0.000 |
Why?
| | Dimethylamines | 1 | 1974 | 4 | 0.000 |
Why?
| | Neoplasm Transplantation | 1 | 1974 | 246 | 0.000 |
Why?
| | Transplantation, Homologous | 1 | 1974 | 418 | 0.000 |
Why?
|
|
Burdick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|